Skip to main content
Log in

Isothermal and Nonisothermal Decomposition of Thymopentin and Its Analogs in Aqueous Solution

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The degradation kinetics of thymopentin (RKDVY) and its analogs (RKDVW and RPDVY) in aqueous solution was studied by isothermal and nonisothermal methods.

Methods. The isothermal decomposition of thymopentin and its analogs was investigated as a function of pH (2−10), temperature (37, 57, and 80°C) and ionic strength (μ = 0.02 to 1). Nonisothermal decomposition studies were performed using a linear temperature programmer. The temperature increasing rate was set to 0.25°C per hour and the temperature interval varied from 40 to 88°C.

Results. The decomposition of thymopentin and its analogs followed first order kinetics. The dependence of the rate constant on temperature followed a linear Arrhenius plot. This indicated that the degradation mechanism of thymopentin and its analogs might be the same within the temperature range studied. The energies of activation were found to be in close agreement for the isothermal and nonisothermal studies, suggesting that the nonisothermal studies may save considerable amount of time in the early stages of drug development. The logK-pH profile of thymopentin suggests that maximum stability is achieved in the pH range of 6−8.

Conclusions. These results indicate that the nonisothermal methodology provides an attractive alternative to isothermal methods, as it requires a much lower amount of both material and time, to determine the peptide stability and to estimate the shelf-life for peptide pharmaceutical preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. E. Audibert. The transitory fusion of coal. Rev. Indust. Min. 6:253–259 (1926).

    Google Scholar 

  2. J. P. Baur, D. W. Bridges, and W. M. Fassel. High pressure oxidation of metals under linear temperature increase. J. Electrochem. Soc. 102:490–496 (1955).

    Google Scholar 

  3. P. Kofstad. Oxidation of metals: Determination of activation energies. Nature 179:1362–1363 (1957).

    Google Scholar 

  4. A. R. Rogers. An accelerated storage test with programmed temperature rise. J. Pharm. Pharmacol. 15:101T–105T (1963).

    Google Scholar 

  5. K. Ellstrom. Non-isothermal stability testing of drug substances in the solid state. Acta Pharm. Suec. 24:115–122 (1987).

    Google Scholar 

  6. J. O. Waltersson and P. Lundgren. Nonisothermal kinetics applied to drugs in pharmaceutical suspensions. Acta. Pharm. Suec. 20:145–154 (1983).

    Google Scholar 

  7. J. E. Kipp. Nonisothermal kinetics-comparison of two methods of data treatment. Int. J. Pharm. 26:339–354 (1985).

    Google Scholar 

  8. J. E. Kipp, M. M. Jensen, K. Kronholm, and M. MsHalsky. Automated liquid chromatography for nonisothermal kinetic studies. Int. J. Pharm. 34:1–8 (1986).

    Google Scholar 

  9. J. E. Kipp and J. J. Hlavaty. Nonisothermal stability assessment of stable pharmaceuticals: testing of a clindamycin phosphate formulation. Pharm. Res. 8:570–575 (1991).

    Google Scholar 

  10. B. R. Cole and L. Leadbeater. A critical assessment of an accelerated storage test. J. Pharm. Pharmacol. 18:101–111 (1966).

    Google Scholar 

  11. B. R. Cole and L. Leadbeater. Estimation of the stability of dry horse serum cholinesterase by means of an accelerated storage test. J. Pharm. Pharmacol. 20:48–53 (1968).

    Google Scholar 

  12. B. W. Madsen, R. A. Anderson, D. Herbison-Evans, and Sneddon. Integral approach to nonisothermal estimation of activation energy. J. Pharm. Sci. 63:777–781 (1974).

    Google Scholar 

  13. G. Goldstein, M. P. Scheid, E. A. Boyse, D. H. Schlesinger, and Van J. Wauwe. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 204:1309–1310 (1979).

    Google Scholar 

  14. D. H. Schlesinger and G. Goldstein. The amino acid sequence of thymopoietin II. Cell 5:361–365 (1975).

    Google Scholar 

  15. T. Audhya, D. H. Schlesinger, and G. Goldstein. Complete amino acid sequences of bovine thymopoietins I, II and III: closely homologous polypeptides. Biochemistry 20:6195–6200 (1981).

    Google Scholar 

  16. G. A. Heavner, T. Audhya, D. Oyle, F. S. Tjoeng, and G. Goldstein. Biologically active conformations of thymopentin. Int. J. Peptide Protein Res. 37:198–209 (1991).

    Google Scholar 

  17. V. J. Helm and B. W. Muller. Stability of the synthetic pentapeptide thymopentin in aqueous solution: effect of pH and buffer on degradation. Int. J. Pharm. 70:29–34 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, ML., Stavchansky, S. Isothermal and Nonisothermal Decomposition of Thymopentin and Its Analogs in Aqueous Solution. Pharm Res 15, 1702–1707 (1998). https://doi.org/10.1023/A:1011952511091

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011952511091

Navigation